Skip to content

Acupuncture as an adjuvant treatment for ischemic stroke: a Pilot Study

Multi-center, randomized controlled trial and related mechanism study of acupuncture therapy for ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004639
Enrollment
Unknown
Registered
2021-01-06
Start date
2021-01-11
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

The Dradging DU Meridian and Recuperating Fundamental Shen acupuncture group:Dradging DU Meridian and Recuperating Fundamental Shen acupuncture

Sponsors

Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients 3-14 days after ischemic stroke; 2. Patients aged 45-75 years; The mini mental state examination (MMSE) score was in the normal range (normal cut-off value: illiteracy > 17, primary school > 20, junior high school and above > 24), which could cooperate with acupuncture, rehabilitation training and related basic treatment; 4. Subjects with modified Rankin score (MRS) less than or equal to 1 before stroke; subjects with NIHSS score between 5 and 15 after stroke; 5. The subjects who knew about the experiment and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Reversible neurological deficits in subjects with transient ischemic attack; 2. Patients with neurological deficit caused by brain tumor, brain trauma, cerebral hemorrhage, brain parasite and other diseases confirmed by examination have a life expectancy of less than one year due to other reasons other than stroke; 3. Patients with contraindications to acupuncture and moxibustion, or stroke complicated with severe primary diseases such as circulatory system, respiratory system, digestive system, urinary system, endocrine system and hematopoiesis system, which can not be controlled by conventional medication; patients complicated with tumor, patients with severe infection, water, electrolytes and acid-base balance disorder; or other abnormal examinations, the researchers judged that they were not suitable to participate in this test The patients who received the examination; 4. Patients with severe aphasia, sleep apnea, deafness, severe cognitive impairment or inability to communicate normally; or those who are participating in other clinical trials; 5. Patients with severe depression, anxiety, or other mental diseases; 6. Women who are pregnant or planning to be pregnant.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale;

Secondary

MeasureTime frame
The changes of FMA motor function scale scores during treatment and follow-up ;The BI score changes during the treatment and follow-up period ;Changes in NIHSS scores during treatment and during follow-up;Comparison of the number of people with different scores of mRS scale;MRI changes;All-cause mortality and recurrent stroke events;The changes of MAS scale scores during treatment and follow-up;

Countries

China

Contacts

Public ContactNenggui Xu

Guangzhou University of Chinese Medicine

ngxu8018@gzucm.com+86 13501524758

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026